Home - Products - Metabolic Enzyme/Protease - PPAR - TCS 359

TCS 359

CAS No. 301305-73-7

TCS 359( TCS359, TCS 359, TCS-359 )

Catalog No. M17469 CAS No. 301305-73-7

TCS 359 is a potent FLT3 inhibitor with IC50 of 42 nM.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	29	In Stock
10MG	46	In Stock
25MG	89	In Stock
50MG	147	In Stock
100MG	191	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

TCS 359
Note

Research use only, not for human use.
Brief Description

TCS 359 is a potent FLT3 inhibitor with IC50 of 42 nM.
Description

TCS-359 is a potent inhibitor of FLT3 with IC50 of 42 nM.
In Vitro

——
In Vivo

——
Synonyms

TCS359, TCS 359, TCS-359
Pathway

Metabolic Enzyme/Protease
Target

PPAR
Recptor

FLT3
Research Area

Cancer
Indication

——

Chemical Information

CAS Number

301305-73-7
Formula Weight

360.43
Molecular Formula

C18H20N2O4S
Purity

>98% (HPLC)
Solubility

DMSO : 14.29 mg/mL 39.65 mM;
SMILES

COC1=CC=C(C=C1OC)C(=O)NC1=C(C(N)=O)C2=C(CCCC2)S1
Chemical Name

2-(3,4-dimethoxybenzamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Raymond J. Patch, et al. Bioorg Med Chem Lett, 2006, 16(12), 3282-3286.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Muraglitazar

Muraglitazar (BMS-298585) is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia.
Ragaglitazar

Ragaglitazar(NNC-61-0029) is a potent dual activator of PPARγ and PPARα, which shows improved insulin sensitization and lipid-lowering potential in animal models and can be used to study type 2 diabetes.
Aleglitazar

A potent and balanced dual PPARα/γ agonist (EC50= 50/21 nM).

Sign In Join Free